Literature DB >> 27066730

Design and Implementation of an Intervention Development Study: Retaining Cognition While Avoiding Late-Life Depression (ReCALL).

Ariel G Gildengers1, Meryl A Butters2, Steven M Albert3, Stewart J Anderson4, Mary Amanda Dew1, Kirk Erickson5, Linda Garand6, Jordan F Karp1, Michael H Lockovich1, Jennifer Morse1, Charles F Reynolds1.   

Abstract

OBJECTIVE: To discuss the design, rationale, and implementation of an intervention development study addressing indicated and selective prevention of depression and anxiety in individuals 60 years and older with mild cognitive impairment (MCI) and in their caregivers.
METHODS: In Phase I, now completed, we developed and standardized problem-solving therapy (PST) and the combined PST + moderate-intensity physical exercise (PE) intervention to be administered to participants with MCI and their caregivers together, dyadically, with both participants working with the same interventionist in the same therapy sessions. In Phase II we have been testing the interventions against enhanced usual care (EUC) and have addressed challenges to recruitment. Randomization was to one of three cells: PST + PE, PST, or EUC.
RESULTS: Although we set out to intervene dyadically, many individuals with MCI lived alone or did not have a support person who could participate in the study with them. Consequently, we modified the study to include MCI participants with and without support persons. Ninety-four participants were enrolled: 20 with MCI together with their support persons (N = 20 dyads) and 54 MCI participants without accompanying support persons. Most participants have been satisfied with the usefulness of the interventions in managing stress and cognitive problems.
CONCLUSION: PST and moderate-intensity PE are acceptable interventions for depression and anxiety prevention in older adults with MCI and their available caregivers.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  aged; depression prevention; mild cognitive impairment; physical exercise; problem-solving therapy

Mesh:

Year:  2015        PMID: 27066730      PMCID: PMC4871778          DOI: 10.1016/j.jagp.2015.10.010

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  40 in total

Review 1.  Sleep, memory and emotion.

Authors:  Matthew P Walker
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

2.  Preventing depression in age-related macular degeneration.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby; William S Tasman
Journal:  Arch Gen Psychiatry       Date:  2007-08

3.  The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease.

Authors:  Paul B Rosenberg; Michelle M Mielke; Brian S Appleby; Esther S Oh; Yonas E Geda; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment.

Authors:  Linda Garand; Mary Amanda Dew; Linda R Eazor; Steven T DeKosky; Charles F Reynolds
Journal:  Int J Geriatr Psychiatry       Date:  2005-06       Impact factor: 3.485

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

6.  Problem adaptation therapy for older adults with major depression and cognitive impairment: a randomized clinical trial.

Authors:  Dimitris N Kiosses; Lisa D Ravdin; James J Gross; Patrick Raue; Nabil Kotbi; George S Alexopoulos
Journal:  JAMA Psychiatry       Date:  2015-01       Impact factor: 21.596

7.  Making sense of mild cognitive impairment: a qualitative exploration of the patient's experience.

Authors:  Jennifer Hagerty Lingler; Marcie C Nightingale; Judith A Erlen; April L Kane; Charles F Reynolds; Richard Schulz; Steven T DeKosky
Journal:  Gerontologist       Date:  2006-12

8.  The effect of subsyndromal symptoms of depression and white matter lesions on disability for individuals with mild cognitive impairment.

Authors:  R Scott Mackin; Philip Insel; Duygu Tosun; Susanne G Mueller; Norbert Schuff; Diana Truran-Sacrey; Sky T Raptentsetsang; Jun-Young Lee; Clifford R Jack; Paul S Aisen; Ronald C Petersen; Michael W Weiner
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

9.  Physical activity reduces the risk of subsequent depression for older adults.

Authors:  William J Strawbridge; Stéphane Deleger; Robert E Roberts; George A Kaplan
Journal:  Am J Epidemiol       Date:  2002-08-15       Impact factor: 4.897

10.  Comparison of the quick mild cognitive impairment (Qmci) screen and the SMMSE in screening for mild cognitive impairment.

Authors:  Rónán O'Caoimh; Yang Gao; Ciara McGlade; Liam Healy; Paul Gallagher; Suzanne Timmons; D William Molloy
Journal:  Age Ageing       Date:  2012-05-18       Impact factor: 10.668

View more
  9 in total

1.  Frequency of But Not Capacity for Participation in Everyday Activities Is Associated With Cognitive Impairment in Late Life.

Authors:  Chao-Yi Wu; Juleen Rodakowski; Lauren Terhorst; Mary Amanda Dew; Meryl Butters; Jordan F Karp; Steven M Albert; Ariel G Gildengers; Charles F Reynolds; Elizabeth R Skidmore
Journal:  J Appl Gerontol       Date:  2021-01-06

2.  Subjective-Objective Sleep Discrepancy in Older Adults With MCI and Subsyndromal Depression.

Authors:  Elizabeth A DiNapoli; Marie Anne Gebara; Terry Kho; Meryl A Butters; Ariel G Gildengers; Steven M Albert; Mary Amanda Dew; Kirk I Erickson; Charles F Reynolds; Jordan F Karp
Journal:  J Geriatr Psychiatry Neurol       Date:  2017-09-27       Impact factor: 2.680

3.  Depressive symptoms and cerebral microvascular disease in adults with Type 1 diabetes mellitus.

Authors:  K A Nunley; J F Karp; T J Orchard; T Costacou; H J Aizenstein; J R Jennings; C Rosano
Journal:  Diabet Med       Date:  2019-01-18       Impact factor: 4.359

4.  Treatment Considerations for Depression Research in Older Married Couples: A Dyadic Case Study.

Authors:  Sarah T Stahl; Juleen Rodakowski; Ariel G Gildengers; Charles F Reynolds; Jennifer Q Morse; Kevin Rico; Meryl A Butters
Journal:  Am J Geriatr Psychiatry       Date:  2017-01-04       Impact factor: 4.105

Review 5.  Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.

Authors:  Vasiliki Orgeta; Phuong Leung; Rafael Del-Pino-Casado; Afifa Qazi; Martin Orrell; Aimee E Spector; Abigail M Methley
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

6.  The Effects of Gait Speed and Psychomotor Speed on Risk for Depression and Anxiety in Older Adults with Medical Comorbidities.

Authors:  Sarah T Stahl; Helene M Altmann; Mary Amanda Dew; Steven M Albert; Meryl Butters; Ariel Gildengers; Charles F Reynolds; Jordan F Karp
Journal:  J Am Geriatr Soc       Date:  2021-01-02       Impact factor: 5.562

7.  Subjective Sleep Quality and Trajectories of Interleukin-6 in Older Adults.

Authors:  Sarah T Stahl; Stephen F Smagula; Juleen Rodakowski; Mary Amanda Dew; Jordan F Karp; Steven M Albert; Meryl Butters; Ariel Gildengers; Charles F Reynolds
Journal:  Am J Geriatr Psychiatry       Date:  2020-06-25       Impact factor: 4.105

8.  Effectiveness of a group-based psychosocial program to prevent depression and anxiety in older people attending primary health care centres: a randomised controlled trial.

Authors:  Sandra Saldivia; Carolina Inostroza; Claudio Bustos; Paulina Rincón; Joseph Aslan; Vasily Bühring; Maryam Farhang; Michael King; Félix Cova
Journal:  BMC Geriatr       Date:  2019-08-29       Impact factor: 3.921

Review 9.  Psychotherapeutic interventions in individuals at risk for Alzheimer's dementia: a systematic review.

Authors:  Ayda Rostamzadeh; Anna Kahlert; Franziska Kalthegener; Frank Jessen
Journal:  Alzheimers Res Ther       Date:  2022-01-31       Impact factor: 8.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.